Edition:
United Kingdom

Lee's Pharmaceutical Holdings Ltd (0950.HK)

0950.HK on Hong Kong Stock

11.84HKD
23 Feb 2018
Change (% chg)

HK$-0.26 (-2.15%)
Prev Close
HK$12.10
Open
HK$12.20
Day's High
HK$12.70
Day's Low
HK$11.80
Volume
3,239,500
Avg. Vol
1,463,427
52-wk High
HK$14.70
52-wk Low
HK$6.01

Chart for

About

Lee’s Pharmaceutical Holdings Limited is a Hong Kong-based investment holding company principally engaged in the development, manufacture, marketing and sales of pharmaceutical products. The Company operates through two segments. Proprietary Products segment is engaged in the manufacture and sales of self-developed pharmaceutica... (more)

Overall

Beta: 0.88
Market Cap(Mil.): HK$3,634.30
Shares Outstanding(Mil.): 590.94
Dividend: 0.03
Yield (%): 1.84

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.91 10.66
ROE: -- 16.41 14.30

BRIEF-Lee's Pharmaceutical Holdings Says China FDA Grants Unit Approval For Clinical Trials

* CHINA FDA GRANTS UNIT APPROVAL FOR CLINICAL TRIALS FOR ITS RECOMBINANT HUMAN ANTI-PD-L1 MONOCLONAL ANTIBODY INJECTION Source text for Eikon: Further company coverage:

29 Jan 2018

BRIEF-Lee's Pharmaceutical Says ‍Zhaoke Pharmaceutical & Zhaoke Oncology Entered Agreement​

* ‍ZHAOKE PHARMACEUTICAL & ZHAOKE ONCOLOGY ENTERED INTO SALE AND PURCHASE AGREEMENT​

29 Dec 2017

BRIEF-Lee's Pharmaceutical Holdings says ‍qtrly profit attributable HK$61.8 mln

* ‍Qtrly profit attributable to owners of company HK$61.8 million versus HK$72.8 million

23 Nov 2017

BRIEF-Lee's Pharmaceutical Holdings says ‍interim dividend hk$0.034 per ordinary share​

* Hy profit attributable hk$78.690 million versus hk$68.311 million Source text for Eikon: Further company coverage:

24 Aug 2017

Earnings vs. Estimates